Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Flash BioSolutions logo — CDMO expert specialized in gene delivery

Flash BioSolutions

CDMO expert specialized in gene delivery

Founded 2005 France France 51 employees Debt Financing Total: $18.30M Biotechnology, Health Care

General Information

Company Name Flash BioSolutions
Founded Year 2005
Location France France
Employees 51
Industries Biotechnology, Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Flash BioSolutions. To contact Flash BioSolutions, visit flashtherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Flash BioSolutions compare?

A PDF of Flash BioSolutions and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Flash BioSolutions soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Flash BioSolutions

Flash Therapeutics is a biotechnology startup based in France, founded in 2018. The company specializes in lentiviral vector manufacturing and is focused on gene delivery. Flash BioSolutions offers a range of products and services, including integrative lentiviral vectors and RNA particles under the brand names LentiCare® and FlashRNA®. These products cater to a variety of applications, such as gene therapy, immunotherapy, regenerative medicine, gene editing, and vaccination/immunotherapy studies.

The company recently secured a €15.00M debt financing investment on 07 August 2021, with the participation of Elaia Partners and TECHLIFE CAPITAL as the investors. Flash Therapeutics' offerings, coupled with its recent investment, position it as a promising player in the biotechnology and healthcare industries. With its expertise in gene delivery and strong investor backing, Flash Therapeutics is poised for growth and impact in the life sciences sector.

Business keywords: gene therapy, lentiviral delivery, bioproduction, start-up, French startup, Toulouse-based, bio-production technologies, cell-based treatments, exclusive technology, innovation, lentiviral platform

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing €15.00M 2
Elaia TECHLIFE CAPITAL
Elaia, TECHLIFE CAPITAL
07 Aug 2021
Private Equity Round €3.30M 4
Auriga Partners GALIA GESTION
Auriga Partners, GALIA GESTION +2
16 May 2018

Flash BioSolutions Alternatives & Competitors

View All Alternatives
Flash BioSolutions vs
Kelonia Therapeutics
Kelonia Therapeutics United States

Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.

Private Equity
74 employees
Biotechnology, Health Care
Compare Flash BioSolutions vs Kelonia Therapeutics
Flash BioSolutions vs
bluebird bio
bluebird bio United States

Pursuing curative gene therapies to give patients and their families more bluebird days.

IPO
548 employees
Biotechnology, Health Care
Compare Flash BioSolutions vs bluebird bio
Flash BioSolutions vs
Eureka Biotechnology Co., Limited
Eureka Biotechnology Co., Limited China

Provider of lentiviral vector stable producer cell line system and GMP closed automated equipment fo...

Series B
8 employees
Biotechnology, Health Care
Also compare with: Flash BioSolutions vs American Gene Technologies® International Inc. American Gene Technologies® International Inc. View all alternatives

FAQ About Flash BioSolutions

CDMO expert specialized in gene delivery
Flash BioSolutions was founded in 2005.
Flash BioSolutions is headquartered in France.
Flash BioSolutions operates in Biotechnology and Health Care. Its work centres on gene therapy, lentiviral delivery, bioproduction and start-up.
Flash BioSolutions has approximately 51 employees.
Flash BioSolutions has completed 2 funding rounds, raising a total of $18.30M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Flash BioSolutions include Kelonia Therapeutics, bluebird bio, Eureka Biotechnology Co., Limited, Altheia Science, Sana Biotechnology, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Flash BioSolutions and Kelonia Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Flash BioSolutions, https://bouncewatch.com/company/flash-therapeutics, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes